Massive hemothorax following administration of intrapleural streptokinase

The administration of intrapleural streptokinase (IPSK) is widely practiced in the management of loculated empyema thoracis. To our knowledge, there have been only 4 cases of hemorrhagic complications attributed to the administration of IPSK reported in the literature. In this article, we report a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Feng Yih, Kuan, Yeh Chunn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131759/
https://www.ncbi.nlm.nih.gov/pubmed/21760848
http://dx.doi.org/10.4103/1817-1737.82451
_version_ 1782207756988579840
author Chai, Feng Yih
Kuan, Yeh Chunn
author_facet Chai, Feng Yih
Kuan, Yeh Chunn
author_sort Chai, Feng Yih
collection PubMed
description The administration of intrapleural streptokinase (IPSK) is widely practiced in the management of loculated empyema thoracis. To our knowledge, there have been only 4 cases of hemorrhagic complications attributed to the administration of IPSK reported in the literature. In this article, we report a case of a 17-year-old girl who received IPSK and developed shock, anemia, coagulopathy and massive hemothorax. Our discussion focuses on the hemorrhagic complication of chest tube insertion and the role of IPSK in blood clot lysis and inhibition of local hemostasis.
format Online
Article
Text
id pubmed-3131759
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31317592011-07-14 Massive hemothorax following administration of intrapleural streptokinase Chai, Feng Yih Kuan, Yeh Chunn Ann Thorac Med Case Report The administration of intrapleural streptokinase (IPSK) is widely practiced in the management of loculated empyema thoracis. To our knowledge, there have been only 4 cases of hemorrhagic complications attributed to the administration of IPSK reported in the literature. In this article, we report a case of a 17-year-old girl who received IPSK and developed shock, anemia, coagulopathy and massive hemothorax. Our discussion focuses on the hemorrhagic complication of chest tube insertion and the role of IPSK in blood clot lysis and inhibition of local hemostasis. Medknow Publications 2011 /pmc/articles/PMC3131759/ /pubmed/21760848 http://dx.doi.org/10.4103/1817-1737.82451 Text en Copyright: © Annals of Thoracic Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Chai, Feng Yih
Kuan, Yeh Chunn
Massive hemothorax following administration of intrapleural streptokinase
title Massive hemothorax following administration of intrapleural streptokinase
title_full Massive hemothorax following administration of intrapleural streptokinase
title_fullStr Massive hemothorax following administration of intrapleural streptokinase
title_full_unstemmed Massive hemothorax following administration of intrapleural streptokinase
title_short Massive hemothorax following administration of intrapleural streptokinase
title_sort massive hemothorax following administration of intrapleural streptokinase
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131759/
https://www.ncbi.nlm.nih.gov/pubmed/21760848
http://dx.doi.org/10.4103/1817-1737.82451
work_keys_str_mv AT chaifengyih massivehemothoraxfollowingadministrationofintrapleuralstreptokinase
AT kuanyehchunn massivehemothoraxfollowingadministrationofintrapleuralstreptokinase

Ejemplares similares